A phase II study of Halichondrin B analog eribulin mesylate (E7389) as second-line therapy for patients with advanced pancreatic cancer Conference Paper uri icon

  •  
  • Overview
  •  
  • Research
  •  
  • Additional Document Info
  •  
  • View All
  •  

authors

  • Moore, MJ
  • Tang, P
  • Renouf, D
  • Major, Pierre
  • Hedley, D
  • Paterson, V
  • Wang, L
  • Dhesy-Thind, B
  • Southwood, B
  • Doyle, L

publication date

  • May 20, 2009